Results 181 to 190 of about 5,730 (206)

Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies

Journal of Hepatology, 2015
Thierry Verbinnen, Leen Vijgen, Hugo Ceulemans   +2 more
exaly  

Simeprevir (TMC435) With Pegylated Interferon/Ribavirin in Patients Coinfected With HCV Genotype 1 and HIV-1: A Phase 3 Study

Clinical Infectious Diseases, 2014
Douglas T Dieterich, Chloe Orkin, Felix Gutierrez   +2 more
exaly  

Daclatasvir/simeprevir

Reactions Weekly, 2016
openaire   +1 more source

Simeprevir/sofosbuvir

Reactions Weekly, 2020
openaire   +1 more source

Simeprevir with peginterferon/ribavirin for treatment-naïve hepatitis C genotype 1 patients in Japan: CONCERTO-1, a phase III trial

Journal of Hepatology, 2014
Namiki Izumi
exaly  

Antiviral effects of simeprevir on multiple viruses

Antiviral Research, 2019
Yongfen Xu, Ailing Lu, Jin Zhong
exaly  

Development of a simple HPLC–UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasma

Journal of Pharmaceutical and Biomedical Analysis, 2016
Giulio Nannetti, Alfredo Alberti, Arianna Loregian   +2 more
exaly  

Ciclosporin/simeprevir

Reactions Weekly, 2017
openaire   +1 more source

Determination of simeprevir: A novel, hepatitis C protease inhibitor in human plasma by high-performance liquid chromatography–tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2014
Tom Verhaeghe
exaly  

Daclatasvir/simeprevir/sofosbuvir

Reactions Weekly, 2018
openaire   +1 more source